Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells

Metastatic prostate cancer (PCa) cells soiling in the bone require a metabolic adaptation. Here, we identified the metabolic genes fueling the seeding of PCa in the bone niche. Using a transwell co-culture system of PCa (PC3) and bone progenitor cells (MC3T3 or Raw264.7), we assessed the transcripto...

Full description

Bibliographic Details
Main Authors: Pablo Sanchis, Nicolas Anselmino, Sofia Lage-Vickers, Agustina Sabater, Rosario Lavignolle, Estefania Labanca, Peter D. A. Shepherd, Juan Bizzotto, Ayelen Toro, Antonina Mitrofanova, Maria Pia Valacco, Nora Navone, Elba Vazquez, Javier Cotignola, Geraldine Gueron
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/9/2083
_version_ 1797505468364488704
author Pablo Sanchis
Nicolas Anselmino
Sofia Lage-Vickers
Agustina Sabater
Rosario Lavignolle
Estefania Labanca
Peter D. A. Shepherd
Juan Bizzotto
Ayelen Toro
Antonina Mitrofanova
Maria Pia Valacco
Nora Navone
Elba Vazquez
Javier Cotignola
Geraldine Gueron
author_facet Pablo Sanchis
Nicolas Anselmino
Sofia Lage-Vickers
Agustina Sabater
Rosario Lavignolle
Estefania Labanca
Peter D. A. Shepherd
Juan Bizzotto
Ayelen Toro
Antonina Mitrofanova
Maria Pia Valacco
Nora Navone
Elba Vazquez
Javier Cotignola
Geraldine Gueron
author_sort Pablo Sanchis
collection DOAJ
description Metastatic prostate cancer (PCa) cells soiling in the bone require a metabolic adaptation. Here, we identified the metabolic genes fueling the seeding of PCa in the bone niche. Using a transwell co-culture system of PCa (PC3) and bone progenitor cells (MC3T3 or Raw264.7), we assessed the transcriptome of PC3 cells modulated by soluble factors released from bone precursors. In a Principal Component Analysis using transcriptomic data from human PCa samples (GSE74685), the altered metabolic genes found in vitro were able to stratify PCa patients in two defined groups: primary PCa and bone metastasis, confirmed by an unsupervised clustering analysis. Thus, the early transcriptional metabolic profile triggered in the in vitro model has a clinical correlate in human bone metastatic samples. Further, the expression levels of five metabolic genes (<i>VDR, PPARA, SLC16A1, GPX1</i> and <i>PAPSS2</i>) were independent risk-predictors of death in the SU2C-PCF dataset and a risk score model built using this lipid-associated signature was able to discriminate a subgroup of bone metastatic PCa patients with a 23-fold higher risk of death. This signature was validated in a PDX pre-clinical model when comparing MDA-PCa-183 growing intrafemorally vs. subcutaneously, and appears to be under the regulatory control of the Protein Kinase A (PKA) signaling pathway. Secretome analyses of conditioned media showcased fibronectin and type-1 collagen as critical bone-secreted factors that could regulate tumoral PKA. Overall, we identified a novel lipid gene signature, driving PCa aggressive metastatic disease pointing to PKA as a potential hub to halt progression.
first_indexed 2024-03-10T04:19:01Z
format Article
id doaj.art-7f3e5d12d2ba488893597ef8758111a8
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T04:19:01Z
publishDate 2022-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7f3e5d12d2ba488893597ef8758111a82023-11-23T07:54:35ZengMDPI AGCancers2072-66942022-04-01149208310.3390/cancers14092083Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer CellsPablo Sanchis0Nicolas Anselmino1Sofia Lage-Vickers2Agustina Sabater3Rosario Lavignolle4Estefania Labanca5Peter D. A. Shepherd6Juan Bizzotto7Ayelen Toro8Antonina Mitrofanova9Maria Pia Valacco10Nora Navone11Elba Vazquez12Javier Cotignola13Geraldine Gueron14Laboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Genitourinary Medical Oncology and The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Genitourinary Medical Oncology and The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Genitourinary Medical Oncology and The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Biomedical and Health Informatics, Rutgers School of Health Professions, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 07101, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaDepartment of Genitourinary Medical Oncology and The David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USALaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaLaboratorio de Inflamación y Cáncer, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires C1428EGA, ArgentinaMetastatic prostate cancer (PCa) cells soiling in the bone require a metabolic adaptation. Here, we identified the metabolic genes fueling the seeding of PCa in the bone niche. Using a transwell co-culture system of PCa (PC3) and bone progenitor cells (MC3T3 or Raw264.7), we assessed the transcriptome of PC3 cells modulated by soluble factors released from bone precursors. In a Principal Component Analysis using transcriptomic data from human PCa samples (GSE74685), the altered metabolic genes found in vitro were able to stratify PCa patients in two defined groups: primary PCa and bone metastasis, confirmed by an unsupervised clustering analysis. Thus, the early transcriptional metabolic profile triggered in the in vitro model has a clinical correlate in human bone metastatic samples. Further, the expression levels of five metabolic genes (<i>VDR, PPARA, SLC16A1, GPX1</i> and <i>PAPSS2</i>) were independent risk-predictors of death in the SU2C-PCF dataset and a risk score model built using this lipid-associated signature was able to discriminate a subgroup of bone metastatic PCa patients with a 23-fold higher risk of death. This signature was validated in a PDX pre-clinical model when comparing MDA-PCa-183 growing intrafemorally vs. subcutaneously, and appears to be under the regulatory control of the Protein Kinase A (PKA) signaling pathway. Secretome analyses of conditioned media showcased fibronectin and type-1 collagen as critical bone-secreted factors that could regulate tumoral PKA. Overall, we identified a novel lipid gene signature, driving PCa aggressive metastatic disease pointing to PKA as a potential hub to halt progression.https://www.mdpi.com/2072-6694/14/9/2083prostate cancerbone metastasismetabolismgene signaturelipid metabolismPKA
spellingShingle Pablo Sanchis
Nicolas Anselmino
Sofia Lage-Vickers
Agustina Sabater
Rosario Lavignolle
Estefania Labanca
Peter D. A. Shepherd
Juan Bizzotto
Ayelen Toro
Antonina Mitrofanova
Maria Pia Valacco
Nora Navone
Elba Vazquez
Javier Cotignola
Geraldine Gueron
Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
Cancers
prostate cancer
bone metastasis
metabolism
gene signature
lipid metabolism
PKA
title Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
title_full Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
title_fullStr Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
title_full_unstemmed Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
title_short Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells
title_sort bone progenitors pull the strings on the early metabolic rewiring occurring in prostate cancer cells
topic prostate cancer
bone metastasis
metabolism
gene signature
lipid metabolism
PKA
url https://www.mdpi.com/2072-6694/14/9/2083
work_keys_str_mv AT pablosanchis boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT nicolasanselmino boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT sofialagevickers boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT agustinasabater boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT rosariolavignolle boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT estefanialabanca boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT peterdashepherd boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT juanbizzotto boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT ayelentoro boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT antoninamitrofanova boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT mariapiavalacco boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT noranavone boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT elbavazquez boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT javiercotignola boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells
AT geraldinegueron boneprogenitorspullthestringsontheearlymetabolicrewiringoccurringinprostatecancercells